Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,127.20
(
0.47%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
98.60
(
-2.04%
)
Bitcoin
74,102.86
(
0.22%
)
News Focus
News Focus
Post# of 312
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: 10nisman post# 21

Thursday, 09/10/2009 12:54:59 PM

Thursday, September 10, 2009 12:54:59 PM

Post# of 312

Assuming the 2010 guidance is accurate MON will likely see the $60's or at best be range bound for many months.

It won’t go back to the 60s, IMO.

In a post on the Biotech Values board a few months ago, I predicted a “solution” for MON’s declining sales in the Roundup segment. Do you remember what it was?

p.s. Welcome to the board!


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now